All entries for: Novo Nordisk

October 16, 2025

Novo Nordisk

Layoffs

Denmark
50,001+ employees

As part of its restructuring that includes cutting about 9,000 employees globally, Novo Nordisk is laying off U.S. employees this week and continuing into next week. Reuters noted that based on an email it received, affected departments include HR, clinical development, rare diseases, medical and regulatory, legal, ethics and compliance, marketing and sales, finance and public affairs.

Disease Area: Chronic Disease, Metabolic Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
October 14, 2025

Novo Nordisk

Layoffs

Denmark
50,001+ employees

Almost all of Novo’s 250 cell therapy employees will be laid off, Fierce reported, citing the Danish outlet Borsen.

Disease Area: Chronic Disease, Metabolic Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
September 19, 2025

Novo Nordisk

Layoffs

Denmark
50,001+ employees

Novo Nordisk will let go of 263 employees at its U.S. headquarters in Plainsboro, New Jersey, effective Dec. 31.

Disease Area: Chronic Disease, Metabolic Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
September 11, 2025

Novo Nordisk

Layoffs

Denmark
50,001+ employees

Novo Nordisk is cutting some 9,000 staff across its global operations, including around 5,000 in Denmark, in a bid to generate around $1.25 billion in annualized savings through 2026. The layoffs, which amount to an 11% headcount reduction, will begin “immediately,” and Novo expects to incur 9 billion Danish Kroner ($1.41 billion) in one-off costs, which will reflect in third-quarter 2025 results.

Disease Area: Chronic Disease, Metabolic Diseases, Neurological Diseases, Rare Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top